HEPSANET at COLDA 2023

HEPSANET members were well represented at the Conference on Liver Disease in Africa 2023 which was on 7-9th September in Dar Es Salaam.

HEPSANET posters were presented describing the cohort, and projecting the impact of potential revised treatment eligibility criteria, and an oral presentation examined associations between sex, geography and HBV DNA and HBeAg.

Previous
Previous

New paper: A new approach to prevent, diagnose, and treat hepatitis B in Africa

Next
Next

Africa CDC- HEPSANET joint training